Immunomodulator for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Also improve overall survival in myeloma (which generally carries a poor prognosis), although toxicity remains an issue for users.
Capsule
8404 EGP
Immunomodulator for multiple myeloma, for which thalidomide is an accepted therapeutic treatment. Also shown efficacy in the class of hematological disorders known as myelodysplastic syndromes (MDS). Also improve overall survival in myeloma (which generally carries a poor prognosis), although toxicity remains an issue for users.
Note: All the provided information about this drug does not substitute for consulting a doctor.